SCHEMBL3137447

SCHEMBL3137447

O=S(=O)(O)CCNO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8089243 0.97 PTGS1 (0.41)
SCHEMBL6059426 0.82 APP (0.48)
SCHEMBL6901692 0.82
SCHEMBL8481986 0.78 PTGS1 (0.45)
SCHEMBL1805336 0.78 PTGS1 (0.45)
SCHEMBL30026428 0.75 PTGS1 (0.43)
SCHEMBL19865717 0.75
SCHEMBL4883135 0.75 PTGS1 (0.38)
SCHEMBL14788902 0.73
SCHEMBL167373 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022269026-A1 TREATING ACETAMINOPHEN OVERDOSE FORSCHUNGSGESELLSCHAFT FÜR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E. V. (DE) 2022-12-29 WO claimed
EP-1377877-A4 STABILIZED CD-4 ONE-PART FILM DEVELOPER CONCENTRATES TREBLA CHEMICAL COMPANY (US) 2004-12-15 EP claimed
US-20040110729-A1 Primary N-hydroxylamines NIH 2004-06-10 US claimed
EP-1377877-A1 STABILIZED CD-4 ONE-PART FILM DEVELOPER CONCENTRATES Trebla Chemical Company (US) 2004-01-07 EP claimed
WO-2003003116-A1 STABILIZED CD-4 ONE-PART FILM DEVELOPER CONCENTRATES TREBLA CHEMICAL COMPANY (US) 2003-01-09 WO claimed
US-6455589-B1 AN ORALLY ADMINISTRABLE EFFECTIVE UNIT SOLID DOSAGE OF A PRIMARY N-HYDROXYLAMINE OR A SALT, FREE OF NITRONE; USEFUL FOR REDUCING OXIDATIVE DAMAGE OR DELAYING SENESCENCE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-09-24 US claimed
US-20250199015-A1 CYCLIN-DEPENDENT KINASE 2 INHIBITORS FOR MEDICAL TREATMENT INCYCLIX BIO, LLC (US) 2025-06-19 US disclosed
EP-4540256-A2 CYCLIN-DEPENDENT KINASE 2 INHIBITORS FOR MEDICAL TREATMENT Incyclix Bio, LLC (US) 2025-04-23 EP disclosed
CN-119403808-A Cyclin-dependent kinase 2 inhibitors for medical treatment 因西克利克斯生物有限责任公司 2025-02-07 CN disclosed
WO-2023249974-A2 CYCLIN-DEPENDENT KINASE 2 INHIBITORS FOR MEDICAL TREATMENT INCYCLIX BIO, INC. (US) 2023-12-28 WO disclosed
EP-3365330-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 EP disclosed
US-11548860-B2 Pharmacophores, compounds and methods having application in the treatment of cancer through inhibition of CYP17A1 and CYP19A1 MANGOSUTHU UNIVERSITY OF TECHNOLOGY (ZA) 2023-01-10 US disclosed
WO-2022269026-A1 TREATING ACETAMINOPHEN OVERDOSE FORSCHUNGSGESELLSCHAFT FÜR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E. V. (DE) 2022-12-29 WO disclosed
EP-0915370-A1 Silver halide light-sensitive photographic material KONICA CORPORATION (JP) 1999-05-12 EP disclosed
US-5891608-A DEVELOPMENT OF PHOTOGRAPHY FUJI PHOTO FILM CO., LTD. (JP) 1999-04-06 US disclosed
EP-0654709-B1 Container of solid processing agent used for silver halide photosensitive material KONISHIROKU PHOTO IND (JP) 1999-03-03 EP disclosed
US-5780210-A Color developing agent, silver halide photographic light-sensitive material and image forming method FUJI PHOTO FILM CO., LTD. (JP) 1998-07-14 US disclosed
US-5695913-A USING A DYE-FORMING COUPLER AND A REDUCING AGENT FUJI PHOTO FILM CO., LTD. (JP) 1997-12-09 US disclosed
US-5617954-A Container of solid processing agent used for silver halide photosensitive material KONICA CORPORATION (JP) 1997-04-08 US disclosed
EP-0654709-A1 Container of solid processing agent used for silver halide photosensitive material KONICA CORPORATION (JP) 1995-05-24 EP disclosed